DPP-IV. The structure-activity relationships (SAR) led to the discovery of novel series of DPP-IV inhibitors, having IC50 values of <100 nM with excellent selectivity over the closely related enzymes, DPP8, DPP-II and FAP. The studies identified a potent and selective DPP-IV inhibitor 24b, which exhibited the ability to both significantly inhibit plasma DPP-IV activity in rats and improve glucose tolerance
合成了一系列反式-2-芳基-
环丙胺衍生的化合物,并评估了其对
DPP-IV的
生物学活性。构效关系(
SAR)导致发现了一系列新的
DPP-IV
抑制剂,其IC 50值<100 nM,对密切相关的酶DPP8,DPP-II和FAP具有优异的选择性。研究确定了一种有效的选择性DPP-IV抑制剂24b,该抑制剂具有显着抑制大鼠血浆DPP-IV活性并改善瘦小鼠和饮食诱发的肥胖小鼠对
葡萄糖的耐受性的能力。